Eledon Pharmaceuticals, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
ELDN on Nasdaq
Location
19800 Macarthur Blvd., Suite 250, Irvine, CA

Insiders trading volume in the past year

Eledon Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bvf Partners L P/Il 10%+ Owner $3.63M +$17.3M Oct 29, 2024
David-Alexandre C. Gros Chief Executive Officer, Director $1.57M Jan 10, 2025
Steven Perrin President, Director $1.3M Jan 10, 2025
Keith Katkin Director $1.17M Jan 10, 2025
Paul Little Chief Financial Officer $814K Jan 10, 2025
Bryan Smith General Counsel, Corporate Sec $735K Jan 10, 2025
Lyons Gary A Director $422K May 1, 2023
Walter Ogier Director $233K May 1, 2023
James A. Robinson Jr. Director $233K Jan 10, 2025
Jan Hillson Director $233K Jan 10, 2025
June Lee Director $233K Jan 10, 2025
John McBride Director $233K Jan 10, 2025
Allan Kirk Director $233K Jan 10, 2025

Recent Insider Transactions by Companies or Individuals for Eledon Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.